Literature DB >> 28483762

Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

Florian Zink1, Simon N Stacey1, Gudmundur L Norddahl1, Michael L Frigge1, Olafur T Magnusson1, Ingileif Jonsdottir1,2,3, Thorgeir E Thorgeirsson1, Asgeir Sigurdsson1, Sigurjon A Gudjonsson1, Julius Gudmundsson1, Jon G Jonasson2,3,4, Laufey Tryggvadottir4, Thorvaldur Jonsson2,3, Agnar Helgason1,5, Arnaldur Gylfason1, Patrick Sulem1, Thorunn Rafnar1, Unnur Thorsteinsdottir1,3, Daniel F Gudbjartsson1,6, Gisli Masson1, Augustine Kong1, Kari Stefansson1,3.   

Abstract

Clonal hematopoiesis (CH) arises when a substantial proportion of mature blood cells is derived from a single dominant hematopoietic stem cell lineage. Somatic mutations in candidate driver (CD) genes are thought to be responsible for at least some cases of CH. Using whole-genome sequencing of 11 262 Icelanders, we found 1403 cases of CH by using barcodes of mosaic somatic mutations in peripheral blood, whether or not they have a mutation in a CD gene. We find that CH is very common in the elderly, trending toward inevitability. We show that somatic mutations in TET2, DNMT3A, ASXL1, and PPM1D are associated with CH at high significance. However, known CD mutations were evident in only a fraction of CH cases. Nevertheless, the highly prevalent CH we detect associates with increased mortality rates, risk for hematological malignancy, smoking behavior, telomere length, Y-chromosome loss, and other phenotypic characteristics. Modeling suggests some CH cases could arise in the absence of CD mutations as a result of neutral drift acting on a small population of active hematopoietic stem cells. Finally, we find a germline deletion in intron 3 of the telomerase reverse transcriptase (TERT) gene that predisposes to CH (rs34002450; P = 7.4 × 10-12; odds ratio, 1.37).
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28483762      PMCID: PMC5553576          DOI: 10.1182/blood-2017-02-769869

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia.

Authors:  Andrii I Rozhok; Jennifer L Salstrom; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

Review 2.  Hematopoietic stem cell heterogeneity: subtypes, not unpredictable behavior.

Authors:  Timm Schroeder
Journal:  Cell Stem Cell       Date:  2010-03-05       Impact factor: 24.633

3.  The replication rate of human hematopoietic stem cells in vivo.

Authors:  Sandra N Catlin; Lambert Busque; Rosemary E Gale; Peter Guttorp; Janis L Abkowitz
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

Authors:  L Busque; R Mio; J Mattioli; E Brais; N Blais; Y Lalonde; M Maragh; D G Gilliland
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

5.  Evidence for a multistep pathogenesis of a myelodysplastic syndrome.

Authors:  W H Raskind; N Tirumali; R Jacobson; J Singer; P J Fialkow
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

6.  Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

Authors:  Jan Krönke; Lars Bullinger; Veronica Teleanu; Florian Tschürtz; Verena I Gaidzik; Michael W M Kühn; Frank G Rücker; Karlheinz Holzmann; Peter Paschka; Silke Kapp-Schwörer; Daniela Späth; Thomas Kindler; Marcus Schittenhelm; Jürgen Krauter; Arnold Ganser; Gudrun Göhring; Brigitte Schlegelberger; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

7.  Detection of sharing by descent, long-range phasing and haplotype imputation.

Authors:  Augustine Kong; Gisli Masson; Michael L Frigge; Arnaldur Gylfason; Pasha Zusmanovich; Gudmar Thorleifsson; Pall I Olason; Andres Ingason; Stacy Steinberg; Thorunn Rafnar; Patrick Sulem; Magali Mouy; Frosti Jonsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hreinn Stefansson; Kari Stefansson
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

8.  Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions.

Authors:  Benjamin Werner; Fabian Beier; Sebastian Hummel; Stefan Balabanov; Lisa Lassay; Thorsten Orlikowsky; David Dingli; Tim H Brümmendorf; Arne Traulsen
Journal:  Elife       Date:  2015-10-15       Impact factor: 8.140

9.  (A)symmetric stem cell replication and cancer.

Authors:  David Dingli; Arne Traulsen; Franziska Michor; Fransizka Michor
Journal:  PLoS Comput Biol       Date:  2007-02-01       Impact factor: 4.475

10.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.

Authors:  Andrew L Young; Grant A Challen; Brenda M Birmann; Todd E Druley
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

View more
  219 in total

1.  Insights into the loss of the Y chromosome with age in control individuals and in patients with age-related macular degeneration using genotyping microarray data.

Authors:  Felix Grassmann; Bernhard H F Weber; Reiner A Veitia
Journal:  Hum Genet       Date:  2019-05-27       Impact factor: 4.132

Review 2.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Aging and Hematopoiesis.

Authors:  Emma M Groarke; Neal S Young
Journal:  Clin Geriatr Med       Date:  2019-05-09       Impact factor: 3.076

Review 4.  Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.

Authors:  Lambert Busque; Manuel Buscarlet; Luigina Mollica; Ross L Levine
Journal:  Stem Cells       Date:  2018-06-08       Impact factor: 6.277

5.  Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis.

Authors:  Elina K Cook; Terumi Izukawa; Sherylan Young; Gili Rosen; Mina Jamali; Liying Zhang; Dylan Johnson; Eva Bain; Jamie Hilland; Christina K Ferrone; Jonah Buckstein; Janika Francis; Bushra Momtaz; Amy J M McNaughton; Xudong Liu; Brooke Snetsinger; Rena Buckstein; Michael J Rauh
Journal:  Blood Adv       Date:  2019-08-27

6.  Managing Clonal Hematopoiesis in Patients With Solid Tumors.

Authors:  Kelly L Bolton; Nancy K Gillis; Catherine C Coombs; Koichi Takahashi; Ahmet Zehir; Rafael Bejar; Guillermo Garcia-Manero; Andrew Futreal; Brian C Jensen; Luis A Diaz; Dipti Gupta; Simon Mantha; Virginia Klimek; Elli Papaemmanuil; Ross Levine; Eric Padron
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

7.  On the loss of human sex chromosomes in lymphocytes with age: a quantitative treatment.

Authors:  Reiner A Veitia
Journal:  Eur J Hum Genet       Date:  2018-08-10       Impact factor: 4.246

Review 8.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.

Authors:  Robert L Bowman; Lambert Busque; Ross L Levine
Journal:  Cell Stem Cell       Date:  2018-02-01       Impact factor: 24.633

9.  CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.

Authors:  Soichi Sano; Kosei Oshima; Ying Wang; Yasufumi Katanasaka; Miho Sano; Kenneth Walsh
Journal:  Circ Res       Date:  2018-05-04       Impact factor: 17.367

Review 10.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Blood Adv       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.